Subscribe To
What's in store for united microelectronics (umc) q1 earnings?
United Microelectronics (UMC) first-quarter results are likely to reflect benefits from an expanded 22/28 nanometer portfolio....
Incyte (incy) opzelura gets ec nod for non-segmental vitiligo
Incyte (INCY) gets EC approval for Opzelura (cream formulation of ruxolitinib) for the treatment of non-segmental vitiligo with facial involvement in ...
Looking for a growth stock? 3 reasons why dick's (dks) is a solid choice
Dick's (DKS) is well positioned to outperform the market, as it exhibits above-average growth in financials....
Is inter parfums (ipar) a solid growth stock? 3 reasons to think "yes"
Inter Parfums (IPAR) is well positioned to outperform the market, as it exhibits above-average growth in financials....
3 reasons why growth investors shouldn't overlook federated hermes (fhi)
Federated Hermes (FHI) is well positioned to outperform the market, as it exhibits above-average growth in financials....
3 reasons why growth investors shouldn't overlook w.w. grainger (gww)
W.W. Grainger (GWW) possesses solid growth attributes, which could help it handily outperform the market....
Will hiv and oncology propel gilead's (gild) q1 earnings?
Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports its first-quarter 2023 resul...
W.r. berkley's (wrb) q1 earnings miss, premiums rise y/y
W.R. Berkley's (WRB) Q1 results reflect higher premiums, driven by strong rate increases in nearly all lines of business, exposure growth and an impro...
Are asia etfs better bets than us & europe funds in 2023?
Morgan Stanley believes that Asia investing will likely beat the US and Europe in 2023, as quoted on CNBC....
Will google cloud strength aid alphabet's (googl) q1 earnings?
Alphabet's (GOOGL) first-quarter performance is expected to have benefited from its solid Google Cloud momentum....
What awaits automatic data processing (adp) in q3 earnings?
Automatic Data Processing's (ADP) revenues and earnings are likely to have increased in the third quarter of fiscal 2023....
Armstrong world (awi) to post q1 earnings: what's in store?
Armstrong World's (AWI) Q1 results are likely to reflect strong AUV in the Mineral Fiber segment. Yet, weaker economic conditions are likely to have h...
Mgrx stock: what is going on with mangoceuticals today?
Big moves can be seen on a daily basis in the small-cap space. However, the impressive 175% move in Mangoceuticals (NASDAQ: MGRX ) stock certainly has...
Customers are opting for quick service over casual dining, says former darden ceo clarence otis
Clarence Otis, former CEO of Darden Restaurants, joins 'The Exchange' to discuss restaurants seeing solid sales growth across the industry, weak traff...
Elon musk had a rough week across his empire — tesla, twitter and spacex
Elon Musk's week was capped on Friday when institutional shareholders in Tesla admonished the company's board of directors to rein in the "over-commit...
Final trades: ibm, goldman sachs & more
The "Halftime Report" traders give their top picks to watch for the second half....
Service improvement in the spotlight as csx and union pacific kick off rail earnings
Railroad earnings reporting season kicked off this week with CSX Corp. and Union Pacific Corp. both beating Wall Street's top and bottom line estimate...
Legend bio hits profit-taking zone after reportedly confirming key study results
Legend reportedly confirmed the leaked results of its multiple myeloma study on Friday, leading LEGN stock to surge. The post Legend Bio Hits Profit-T...
Earnings preview: boeing looks to take off stronger in 2023 after string of flops
Boeing missed analysts' earnings expectations in each quarter of 2022, but the company will get another chance to fly higher when it posts its latest ...
Alphabet just made a huge move in the race to dominate artificial intelligence
The artificial intelligence race is heating up, and Microsoft appears to have taken an early lead, but looks can be deceiving. Alphabet CEO Sundar Pic...
Asa: this gold fund can maintain the purchasing power of your wealth
ASA: This Gold Fund Can Maintain The Purchasing Power Of Your Wealth....
Fleetcor technologies to announce first quarter 2023 results on may 3, 2023
ATLANTA--(BUSINESS WIRE)--FLEETCOR Technologies, Inc. (NYSE: FLT), today announced that the Company will host a conference call to discuss first quart...
Hilltop holdings inc. (hth) q1 2023 earnings call transcript
Hilltop Holdings Inc. (HTH) Q1 2023 Earnings Call Transcript....
Benchmark electronics to report first quarter 2023 results
TEMPE, Ariz. , April 21, 2023 /PRNewswire/ -- Benchmark Electronics, Inc. (NYSE: BHE) will announce its first quarter 2023 results on Wednesday, May ...
Glencore's production of copper, zinc, nickel, silver and coal declined in q1 2023
(Kitco News) - Glencore announced yesterday that in Q1 2023, its own sourced copper production was 244,100 tonnes, 5% lower than Q1 2022, largely due ...
Why shares of keros therapeutics jumped this week
Keros is a pre-revenue biotech with two therapies in phase 2 trials. The company focuses on treatments for blood and musculoskeletal disorders....
Tesla stock: why the market has got it all wrong
The market is worried about Tesla's price cuts and declining market share. However, Tesla still leads the EV industry in profit margin....
Gold futures settle under $2,000 an ounce, at lowest in 3 weeks
Gold futures declined on Friday, settling under $2,000 an ounce for the first time in three weeks. Hawkish commentary from Federal Reserve officials �...
Lyft to make ‘significant' cuts across ride-hailing company
Lyft's newly appointed CEO David Risher told employees in an email Friday that the company is significantly reducing its workforce as part of a restru...
Amerant bancorp inc. (amtb) q1 2023 earnings call transcript
Amerant Bancorp Inc. (AMTB) Q1 2023 Earnings Call Transcript....
Synopsys: eda market dominance
Synopsys: EDA Market Dominance....
Intellia therapeutics: signs of possible life
Intellia Therapeutics: Signs Of Possible Life....
Axsome (axsm) focuses on auvelity launch to fuel its growth
Axsome's (AXSM) earnings benefit from the launch of Auvelity (AXS-05), meant for treating major depressive disorders....
Shift4 payments (four) moves to buy: rationale behind the upgrade
Shift4 Payments (FOUR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might driv...
What makes mereo biopharma (mreo) a strong momentum stock: buy now?
Does MEREO BIOPHARMA (MREO) have what it takes to be a top stock pick for momentum investors? Let's find out....